The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics
Abstract
BACKGROUND: Multidrug-resistant Enterobacteriaceae (MRE) are widespread in the community, especially in tropical regions. Travelers are at risk of acquiring MRE in these regions, but the precise extent of the problem is not known. METHODS: From February 2012 to April 2013, travelers attending 6 international vaccination centers in the Paris area prior to traveling to tropical regions were asked to provide a fecal sample before and after their trip. Those found to have acquired MRE were asked to send fecal samples 1, 2, 3, 6, and 12 months after their return, or until MRE was no longer detected. The fecal relative abundance of MRE among all Enterobacteriaceae was determined in each carrier. RESULTS: Among 824 participating travelers, 574 provided fecal samples before and after travel and were not MRE carriers before departure. Of these, 292 (50.9%) acquired an average of 1.8 MRE. Three travelers (0.5%) acquired carbapenemase-producing Enterobacteriaceae. The acquisition rate was higher in Asia (142/196 [72.4%]) than in sub-Saharan Africa (93/195 [47.7%]) or Latin America (57/183 [31.1%]). MRE acquisition was associated with the type of travel, diarrhea, and exposure to β-lactams during the travel. Three months after return, 4.7% of the travelers carried MRE. Carriage lasted longer in travelers returning from Asia and in travelers with a high relative abundance of MRE at return. CONCLUSIONS: MRE acquisition is very frequent among travelers to tropical regions. Travel to these regions should be considered a risk factor of MRE carriage during the first 3 months after return, but not beyond. CLINICAL TRIALS REGISTRATION: NCT01526187.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Interactive metagenomic visualization in a Web browser
Ondov, B. D., Bergman, N. H., & Phillippy, A. M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-385 · Cited by 2,144
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Self-citationTängdén, T., Cars, O., Melhus, A., & Löwdin, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00220-10 · Cited by 372
Kennedy, K., & Collignon, P. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1031-y · Cited by 178
Östholm-Balkhed, Å., Tärnberg, M., Nilsson, M., Nilsson, L. E., Hanberger, H., Hällgren, A., & on behalf of the Travel Study Group of Southeast Sweden (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt167 · Cited by 177
Kuenzli, E., Jaeger, V. K., Frei, R., Neumayr, A. L. C., DeCrom, S., Haller, S., Blum, J. A., Widmer, A. F., Furrer, H., Battegay, M., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-528 · Cited by 142
Ruppé, É., Lixandru, B. E., Cojocaru, R., Büke, Ç., Paramythiotou, E., Angebault, C., Visseaux, C., Djuikoue, C. I., Erdem, E., Burduniuc, O., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-13 · Cited by 140
Self-citationExtended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands
Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid.1908.130257 · Cited by 138
Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands
Paltansing, S., Vlot, J. A., Kraakman, M. E. M., Mesman, R. L. S., Bruijning, M. L., Bernards, A. T., Visser, L. G., & Veldkamp, K. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1908.130257 · Cited by 133
Colonization of Returning Travelers With CTX‐M‐ProducingEscherichia coli
Peirano, G., Laupland, K. B., Gregson, D. B., & Pitout, J. D. D. (2011) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2011.00548.x · Cited by 103
Ruppé, É., Armand-Lefèvre, L., Estellat, C., Mniai, A. E., Boussadia, Y., Consigny, P., Girard, P., Vittecoq, D., Bouchaud, O., Pialoux, G., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.14.20768 · Cited by 80
Self-citationWeisenberg, S. A., Mediavilla, J. R., Chen, L., Alexander, E. L., Rhee, K. Y., Kreiswirth, B. N., & Jenkins, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045141 · Cited by 73
Rogers, B. A., Kennedy, K., Sidjabat, H. E., Jones, M., Collignon, P., & Paterson, D. L. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1584-z · Cited by 53
Cited by
Sartelli, M., Chichom-Mefire, A., Labricciosa, F. M., Hardcastle, T., Abu-Zidan, F. M., Adesunkanmi, A. K., Ansaloni, L., Bala, M., Balogh, Z. J., Beltrán, M. A., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0141-6 · Cited by 494
Mechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Arcilla, M. S., van Hattem, J. M., Haverkate, M. R., Bootsma, M. C. J., van Genderen, P. J. J., Goorhuis, A., Grobusch, M. P., Lashof, A. M. O., Molhoek, N., Schultsz, C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30319-x · Cited by 462
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
Bassetti, M., Poulakou, G., Ruppe, E., Bouza, E., Van Hal, S. J., & Brink, A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4878-x · Cited by 277
Metadata
- Authors
- Ruppé, E., Armand-Lefèvre, L., Estellat, C., Consigny, P.-H., El Mniai, A., Boussadia, Y., Goujon, C., Ralaimazava, P., Campa, P., Girard, P.-M., Wyplosz, B., Vittecoq, D., Bouchaud, O., Le Loup, G., Pialoux, G., Perrier, M., Wieder, I., Moussa, N., Esposito-Farèse, M., Hoffmann, I., Coignard, B., Lucet, J.-C., Andremont, A., & Matheron, S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-22
- Volume
- 61
- Issue
- 4
- Pages
- 593-600
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2165957223
- Cited by
- 278
- References
- 16
- FWCI
- 15.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.